Single-Cell Analysis Market Dynamics and Developments by 2031

Coverage: by Product (Consumables and Instruments), Cell Type (Human Cells, Animal Cells, and Microbial Cells), Technique (Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, and Other Techniques), Application (Research Applications and Medical Applications), and End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, and Cell Banks and IVF Centers), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031
  • Status : Data Released
  • Report Code : TIPBT00002552
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : January 27, 2025
Single-Cell Analysis Market Dynamics and Developments by 2031
Report Date: January 27, 2025   |   Report Code: TIPBT00002552 Email: sales@theinsightpartners.com

2024 Market Size

US$ 5.17 Bn

Base year value

2031 Forecast

US$ 14.35 Bn

Projected by 2031

CAGR 2025-2031

15.7 %

Growth rate

Addressable Market

US$ 67.64 Bn

(2025-2031)

The Single Cell Analysis Market size is expected to reach US$ 14.35 billion by 2031. The market is anticipated to register a CAGR of 15.7% during 2025-2031.

The Single-Cell Analysis Market is categorized by product into the following subsegments: Consumables, Instruments. It further presents an analysis based on cell type, i.e., Human Cells, Animal Cells, Microbial Cells; technique, i.e., Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques; and application, i.e., Research Applications, Medical Applications; and end-user, i.e., Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Cell Banks and IVF Centers. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Single-Cell Analysis Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Single-Cell Analysis Market Segmentation Product

  1. Consumables
  2. Instruments

Cell Type

  1. Human Cells
  2. Animal Cells
  3. Microbial Cells

Technique

  1. Flow Cytometry
  2. Next-Generation Sequencing
  3. Polymerase Chain Reaction
  4. Microscopy
  5. Mass Spectrometry
  6. Other Techniques

Application

  1. Research Applications
  2. Medical Applications

End User

  1. Academic and Research Laboratories
  2. Biotechnology and Pharmaceutical Companies
  3. Hospitals and Diagnostic Laboratories
  4. Cell Banks and IVF Centers

Market Assessment and Insights

  • Global market for Single-Cell Analysis was valued at US$ 5.17 Billion in 2024
  • Annual market size is expected to reach US$ 14.35 Billion by 2031
  • Total addressable market (TAM) during 2025-2031 is projected to reach approximately US$ 67.64 Billion
  • Market is anticipated to register a CAGR of 15.7% during the forecast period
  • The United States represents a key market, supported by Increasing Research in Precision Medicine, Technological Advancements in Single-Cell Technologies, Increasing Research in Cancer and Immunotherapy, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Growth Opportunity in Clinical Diagnostics, Personalized medicine, Technological Innovation in Automation are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Agilent Technologies, Beckman Coulter Inc., Becton Dickinson & Company (BD), Bio-Rad Laboratories, Inc., Fluidigm Corporation, GE Healthcare, Illumina, Inc., Merck KGaA, Qiagen N.V., Thermo Fisher Scientific, Inc., Danaher Corporation, Merck Millipore, 10x Genomics, Promega Corporation, NanoString Technologies, Tecan Group, Sartorius AG, Luminex Corporation, Takara Bio, Fluxion Biosciences, Menarini Silicon Biosystems, LumaCyte, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Single-Cell Analysis Market: Strategic Insights

single-cell-analysis-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Single-Cell Analysis Market Growth Drivers

  1. Increasing Research in Precision Medicine: With the focus on personalized medicine, the need for single-cell analysis is also rising to understand the mechanisms of the diseases and targeted therapies.
  2. Technological Advancements in Single-Cell Technologies: Advancements in single-cell sequencing, CRISPR gene editing, and microfluidics are contributing to the growth of single-cell analysis, because all these enhancements allow more accurate and efficient analyses.
  3. Increasing Research in Cancer and Immunotherapy: Single-cell analysis is increasingly being used in cancer research, particularly to study tumor heterogeneity as well as response to immunotherapies, which is driving the market growth.

Single-Cell Analysis Market Future Trends

  1. Advancements in Single-Cell Sequencing Technologies: The emergence of single-cell RNA sequencing (scRNA-seq) is revolutionizing gene-expression analysis, thereby letting researchers uncover cellular diversity and developmental processes.
  2. Combination of AI and Machine Learning: AI is used for the huge number of data generated in single-cell technologies for better insight and faster results.
  3. Increasing use in drug discovery and development of biomarkers: Single-cell analysis is being applied in research for new markers for disease diagnosis and therapy development, especially in oncology and immunology.

Single-Cell Analysis Market Opportunities

  1. Growth Opportunity in Clinical Diagnostics: Expansion in Clinical Diagnostics In clinical diagnostics, expansion is presented through the ability of single-cell analysis to enhance diagnostic competency, especially in oncology.
  2. Personalized medicine: Individual therapy according to the behavior of their cells opens new avenues for precision medicine and more precise and targeted therapies.
  3. Technological Innovation in Automation: Huge opportunities exist in large-scale research and clinical labs in developing automated single-cell analysis systems that would reduce the costs and increase throughput.

Single-Cell Analysis Market Report Scope

Report Attribute Details
Market size in 2024 US$ 5.17 Billion
Market Size by 2031 US$ 14.35 billion
Global CAGR (2025 - 2031) 15.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Consumables
  • Instruments
By Cell Type
  • Human Cells
  • Animal Cells
  • Microbial Cells
By Technique
  • Flow Cytometry
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microscopy
  • Mass Spectrometry
  • Other Techniques
By Application
  • Research Applications
  • Medical Applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Agilent Technologies
  • Beckman Coulter Inc.
  • Becton Dickinson & Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KGaA
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Merck Millipore
  • 10x Genomics
  • Promega Corporation

Single-Cell Analysis Market Players Density: Understanding Its Impact on Business Dynamics

The Single-Cell Analysis Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

single-cell-analysis-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Single-Cell Analysis Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Single-Cell Analysis Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The leading vendors include: Agilent Technologies, Beckman Coulter Inc., Becton Dickinson & Company (BD), Bio-Rad Laboratories, Inc., Fluidigm Corporation, GE Healthcare, Illumina, Inc., Merck KGaA, Qiagen N.V., Thermo Fisher Scientific, Inc.,

The market is expected to register a CAGR of 15.7% during 2025-2031.

Key trends in the market include incorporation of AI for data analysis, multi-omics approaches with genomics and proteomics amalgamation, and a growing trend in immuno-oncology for cancer research.

Some of the key drivers include the rapid need for precision medicine, advancement in sequencing technology, and ability to analyze cellular behavior in detail-a crucial tool for drug discovery and diagnostics.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA